SELLAS Life Sciences Group Inc. Common Stock vs TTM Technologies Inc. Common Stock — how do they compare? SELLAS Life Sciences Group Inc. Common Stock trades at $11.34 (market cap $2.28B), while TTM Technologies Inc. Common Stock trades at $120.59 (market cap $13.51B). The key difference: TTM Technologies Inc. Common Stock is far larger — about 5.9× SELLAS Life Sciences Group Inc. Common Stock's market cap, and SELLAS Life Sciences Group Inc. Common Stock is trading nearer its 52-week high, TTM Technologies Inc. Common Stock nearer its low. Which is the better fit depends on your goals.
| SLS | TTMI | |
|---|---|---|
Market Cap | $2.28B | $13.51B |
Volume | 3,128,960 | 1,755,886 |
Sector | Health | Technology |
52-Week High | $15.46 | $221.47 |
52-Week Low | $1.39 | $53.58 |
Enterprise Value | $2.15B | $14.11B |
Typical Hold Time | — | 0 Days |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
SELLAS Life Sciences is a late-stage clinical biopharmaceutical company developing therapies for cancer. Its programs include a WT1-targeting cancer immunotherapy and a selective CDK9 inhibitor.
Read more on SLS →TTM Technologies manufactures printed circuit boards, radio-frequency components, and electronics assemblies. Its products are used in aerospace, defense, automotive, data center, and communications equipment.
Read more on TTMI →